Mirimus

Mirimus is a privately held company based in the United States. It employs 88 people and generates $50 million in annual revenue. Founded in 2010, Mirimus specializes in developing innovative diagnostic and monitoring tools, drug discovery solutions, and therapeutic products. The company offers a range of services and products aimed at improving global health. These include customized RNAi and CRISPR Cas9 animal and cell models for drug development, as well as diagnostic technologies for disease detection. Mirimus partners with leading biopharmaceutical companies to advance its pipeline of therapeutic candidates. Mirimus distinguishes itself through its expertise in RNAi and genetic engineering technologies. The company boasts a proven track record of problem-solving, culminating in its recognition as a $1 million grand prize winner of the XPRIZE competition for its development of affordable, rapid, and non-invasive COVID-19 testing methods. For inquiries and collaborations, reach out to Mirimus through their website at mirimus.com.